Publications by authors named "F C Yilmaz"

Segmental duplications (SDs) contribute significantly to human disease, evolution and diversity but have been difficult to resolve at the sequence level. We present a population genetics survey of SDs by analyzing 170 human genome assemblies (from 85 samples representing 38 Africans and 47 non-Africans) in which the majority of autosomal SDs are fully resolved using long-read sequence assembly. Excluding the acrocentric short arms and sex chromosomes, we identify 173.

View Article and Find Full Text PDF

Highly selective inhibitors of cyclin-dependent kinase 4 and 6 (CDK4/6is) have emerged as a standart of care for first- and second-line therapies in combination with endocrine therapy (ET) for HR+/HER2- metastatic breast cancer (MBC) patients. It has been reported that combination therapy is more effective than ET alone and is safe in elderly patients as well as young patients. Nevertheless, elderly and very old patients with HR+/HER2-MBC treated with CDK4/6 inhibitor (CDK4/6i) combinations are relatively underrepresented in randomized controlled trials.

View Article and Find Full Text PDF

Introduction And Objectives: Tissue attenuation reduces the specificity of the myocardial perfusion imaging single photon emission tomography (SPECT), which leads reduced diagnostic accuracy. The aim of this study is to compare performances of non-attenuation corrected (NAC), computed tomography based-attenuation corrected (AC) and prone images for qualitative and semi-quantitative analysis of myocardial perfusion SPECT in diagnosis of coronary artery disease (CAD).

Materials And Methods: Eightysix patients in whom NAC, AC and prone images were obtained with SPECT at Selcuk University Faculty of Medicine, and whose coronary angiography/CT coronary angiography was completed within 3 months, were retrospectively studied.

View Article and Find Full Text PDF
Article Synopsis
  • Bladder carcinoma (BC) is common, with 20% classified as non-muscle invasive bladder cancer (NMIBC), where about 40% of patients experience recurrence despite treatment.
  • The study evaluates the prognostic implications of FOXP3, TIM-3, and tertiary lymphoid structures (TLS) in NMIBC by analyzing patient samples using immunohistochemistry and survival analysis.
  • Findings indicate that higher levels of FOXP3/TLS correlate with better recurrence-free survival, suggesting that FOXP3/TLS may serve as an effective prognostic marker, especially for patients undergoing BCG treatment.
View Article and Find Full Text PDF